Pulsenmore Ltd - Asset Resilience Ratio
Pulsenmore Ltd (PULS) has an Asset Resilience Ratio of 51.61% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Pulsenmore Ltd (PULS) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Pulsenmore Ltd's Asset Resilience Ratio has changed over time. See Pulsenmore Ltd book value and equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Pulsenmore Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Pulsenmore Ltd stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0% |
| Short-term Investments | ILA62.11 Million | 51.61% |
| Total Liquid Assets | ILA62.11 Million | 51.61% |
Asset Resilience Insights
- Very High Liquidity: Pulsenmore Ltd maintains exceptional liquid asset reserves at 51.61% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Pulsenmore Ltd Industry Peers by Asset Resilience Ratio
Compare Pulsenmore Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 50.79% |
|
Sino Medical Sciences Technology In
SHG:688108 |
Medical Devices | 0.66% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
Annual Asset Resilience Ratio for Pulsenmore Ltd (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Pulsenmore Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 44.32% | ILA62.85 Million ≈ $168.51K |
ILA141.83 Million ≈ $380.23K |
-21.19pp |
| 2023-12-31 | 65.51% | ILA117.85 Million ≈ $315.96K |
ILA179.91 Million ≈ $482.33K |
-5.51pp |
| 2022-12-31 | 71.01% | ILA167.81 Million ≈ $449.89K |
ILA236.30 Million ≈ $633.52K |
+46.80pp |
| 2021-12-31 | 24.21% | ILA40.48 Million ≈ $108.51K |
ILA167.16 Million ≈ $448.15K |
-- |
About Pulsenmore Ltd
Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the patient's smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in re… Read more